/biz/ - Business & Finance

>>20867617
SHRMF -53.34%
Most frustrating purchase because they have growth potential and were making legitimate pharma deals but fucked up on trade commission requirements and got halted. They just filed their missing acquisition reports earlier this week so hopefully trading for it opens up again. Part of me wants to double down on it since it's dirt cheap and I think it will at least 2x once it's traded again, but I'm trying my best to avoid gambler's fallacy here.

Part of me doesn't even care about the profits, I just really want to see psychedelics in legitimate pharmaceutical. I personally cured my depression from shroom usage and wouldn't be here trading today if it weren't for the glorious fungi bastards. I know we're still at least a decade away from mainstream acceptance but if people were so hyped over medicinal cannabis use, I don't see how there won't be hype for psychedelics that have use cases that don't overlap with already widely available pharmaceuticals. You can get pain killers over the counter anywhere, but you're not going to get a single dose of something that will cram 1 year of therapy into a single 6 hour trip.

So even if I'm wrong on THIS stock, I hope someone gets the ball rolling. It's a good sign to see more research barriers torn down for these drugs and I definitely see a future for them barring big pharma corruption.